The cost of vaccination throughout life: A western European overview

References

• WHO-Regional Office for Europe. The case for investing in public health. WHO, 2014. http://www.euro.who.int/en/health-topics/Health-systems/public-health-services/publications/2015/the-case-for-investing-in-public-health
   Google Scholar
• Gellin B, Landry S. The value of vaccines: Our Nation's front line against infectious diseases. Clin Pharmacol Ther. 2010; 88:580-1; PMID:20959840; http://dx.doi.org/10.1038/clpt.2010.197
   PubMed Web of Science ®Google Scholar
• Rémy V, Zöllner Y, Heckman U. Vaccination: The cornerstone of an efficient healthcare system. J Market Access Health Policy 2015; 3:27041.
   PubMedGoogle Scholar
• Largeron N, Lévy P, Wasem J, Bresse X. Role of vaccination in the sustainability of healthcare systems. J Market Access Health Policy 2015; 3:27043.
   PubMedGoogle Scholar
• Quilici S, Smith R, Signorelli C. Role of vaccination in economic growth. J Market Access Health Policy. 2015; 3:27044.
   Google Scholar
• Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, Walker DG, Levine OS. Estimated economic benefits during the ‘Decades of Vaccines’ include treatment savings, gains in labor productivity. Health Affairs 2011; 30:1021-1028; PMID:21653952; http://dx.doi.org/10.1377/hlthaff.2011.0382
   PubMed Web of Science ®Google Scholar
• Nelson EAS, Bloom DE, Mahoney RT. Monitoring what governments “give for” and “spend on” vaccine procurement: Vaccine procurement assistance and vaccine procurement baseline. PLOS One. 2014; 9:e89593.
   Google Scholar
• O'Riordan M, Fitzpatrick F. The impact of economic recession on infection prevention and control. J Hospital Infection. 2015; 89:340-5; http://dx.doi.org/10.1016/j.jhin.2014.11.020
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Lionis C. The financial crisis and the expected effects on vaccinations in Europe: a literature review. Infectious Diseases. 2015; 47:437-46; http://dx.doi.org/10.3109/23744235.2015.1018315
   PubMed Web of Science ®Google Scholar
• Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015; 15:533; PMID:26041469
   PubMed Web of Science ®Google Scholar
• Giraldi G, Martinoli L, De Luca d'Alessandro E. The human papillomavirus vaccination: a review of the cost-effectiveness studies. Clin Ther. 2014; 165:e426-32.
   Google Scholar
• Brüggenjürgen B, Lorrot M, Sheppard FR, Rémy V. Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study. Hum Vaccin Immunother. 2014; 10:2290-4; PMID:25424934; http://dx.doi.org/10.4161/hv.29090
   PubMed Web of Science ®Google Scholar
• Garcia-Altes A. Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain? Vaccine 2013; 31:1656-65; PMID:23370153; http://dx.doi.org/10.1016/j.vaccine.2013.01.029
   PubMed Web of Science ®Google Scholar
• Robbins MJ, Jacobson SH. Analytics for vaccine economics and pricing: Insights and observations. Exp Rev Vaccines 2015; 14:605-616; http://dx.doi.org/10.1586/14760584.2015.985662
   PubMed Web of Science ®Google Scholar
• AMELI, Assurance Maladie en Ligne. http://www.codage.ext.cnamts.fr/codif/bdm_it/index_presentation.php?p_site=AMELI (accessed 24.09.2014).
   Google Scholar
• WHO, World Health Organization. http://www.who.int/immunization/monitoring_surveillance/data/en/ (accessed 19.05.2015).
   Google Scholar
• ECDC, European Center for Disease Control. Implementing the ECDC action plan for measles and rubella. Stockholm: ECDC, 2014.
   Google Scholar
• ECDC, European Center for Disease Control. Seasonal influenza vaccination in Europe. Overview of vaccination recommendations and coverages in the EU Member States for the 2012–13 influenza season. Stockholm: ECDC, 2015.
   Google Scholar
• Michel GP, Gusmano M, Blank PR, Philip I. Vaccination and healthy ageing: How to make life-course vaccination a successful public health strategy. Eur Geriatr Med 2010; 1:155-165; http://dx.doi.org/10.1016/j.eurger.2010.03.013
   Web of Science ®Google Scholar
• Pilkinton MA, Talbot HK. Update on vaccination guidelines for older adults. J Am Geriatr Soc 2015; 63:584-588; PMID:25753174; http://dx.doi.org/10.1111/jgs.13375
   PubMed Web of Science ®Google Scholar
• McIntyre CR. Elderly vaccination-The glass is half full. Health 2013; 5:80-85.
   Google Scholar
• Bonnal C, Desaint C, Raynaud-Simon A, Fossey-Diaz V, Gougeon ML, Lucet JC, Launay O. The vaccination of older adults: a challenge for the future!] French. Presse Med 2013; 42:318-26; PMID:22748858; http://dx.doi.org/10.1016/j.lpm.2012.04.024
   PubMed Web of Science ®Google Scholar
• Wu LA, Kanitz E, Crumly J, D'Ancona F, Strikas RA. Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage. Int J Public Health 2013; 58:865-74; PMID:23354183; http://dx.doi.org/10.1007/s00038-012-0438-x
   PubMed Web of Science ®Google Scholar
• Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008; 121:S28-35; PMID:18589065; http://dx.doi.org/10.1016/j.amjmed.2008.05.005
   PubMed Web of Science ®Google Scholar
• Eilers R, Krabbe PFM, van Essen TGA, Suijkerbuijk A, van Lier A, de Melker HE. Assessment of vaccine candidates for persons aged 50 years and older: A review. BMC Geriatrics 2013; 13:32
   PubMed Web of Science ®Google Scholar
• Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, Solana R. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas 2015; 82:50-5; PMID:26044074; http://dx.doi.org/10.1016/j.maturitas.2015.05.004
   PubMed Web of Science ®Google Scholar
• Fulop T, Pawelec G, Castle S, Loeb M. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis 2009; 48:443-8; PMID:19140756; http://dx.doi.org/10.1086/596475
   PubMed Web of Science ®Google Scholar
• Bonanni P, Boccalini S, Bechini A. The expected impact of new vaccines and vaccination policies. J Public Health 2008; 16:253-9; http://dx.doi.org/10.1007/s10389-008-0203-z
   Google Scholar
• RKI, Robert Koch Institut. 2014. http://www.rki.de/EN/Content/Prevention/Vaccination/recommandations/recommendations_node.html (accessed 22 Sept 2014).
   Google Scholar
• NHS, National Health Service. 2014. The complete routine immunisation schedule from summer 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/323504/8807_PHE_Complete_Immunisation_Schedule_A4_2014_11.pdf (accessed 22 Sept 2014).
   Google Scholar
• MASS, Ministère des Affaires Sociales et de la Santé. 2014. Calendrier vaccinal 2014. http://www.sante.gouv.fr/calendrier-vaccinal.html (accessed 26 May 2014).
   Google Scholar
• IMH, Italian Ministry of Health 2014. National vaccination schedule 2014. http://www.salute.gov.it/ (accessed 28 Aug 2014).
   Google Scholar
• MSSSI, Minesterio de Sanidad, Servicios Sociales e Igualdad. 2014. Calendario comun de vacunacione infantil 2015. https://www.msssi.gob.es/ciudadanos/proteccionSalud/vacunaciones/docs/CalendarioVacunacion2015.pdf (accessed 27 Jan 2015).
   Google Scholar
• Folkhälsomyndighten. 2015. http://www.folkhalsomyndigheten.se/documents/smittskydd-sjukdomar/vaccinationer/Barnvaccinationer-tabell.pdf (accessed 2 Mar 2015).
   Google Scholar
• MS, Ministerio da Saude. 2015. Programa Nacional de Vacinaçao 2015. http://www.portaldasaude.pt/portal/conteudos/informacoes+uteis/vacinacao/vacinas.htm (accessed 24 Jul 2015).
   Google Scholar
• WHO, World Health Organization. Life expectancy in 2012. http://apps.who.int/gho/data/?theme=main&vid=60580
   Google Scholar
• Lauer Tax. https://www.lauer-fischer.de/LF/Seiten/Verwaltung/Kundencenter.aspx (accessed 22.09.2014).
   Google Scholar
• NHS, National Health Service. https://www.evidence.nhs.uk/formulary (accessed 11.09.2014).
   Google Scholar
• AMELI, Assurance Maladie en Ligne. http://www.codage.ext.cnamts.fr/codif/bdm_it//labo/index_lis_labo_detail.php?p_code_fabrican=1088&p_site=AMELI&p_homol_ass=ass&p_homol_coll (accessed 26.05.2014).
   Google Scholar
• AIFA, Agenzia Italiana del Farmaco. http://www.agenziafarmaco.gov.it/en/content/pricing-and-reimbursement. (accessed 28.08.2014).
   Google Scholar
• Colegio Oficial de Farmaceuticos. http://www.portalfarma.com/inicio/botplus20/Paginas/Bot-PLUS-2-0.aspx (accessed 27.01.2015).
   Google Scholar
• Apotek. http://www.apoteket.se (accessed 27.01.2015).
   Google Scholar
• INFARMED, Autoridade Nacional do Medicamento e Produtos de Saude. http://www.infarmed.pt (accessed 24.07.2015).
   Google Scholar
• Italian Health Ministry. Art. 9, Law n. 386/74 of the Italian Health Ministry (17.08.1974).
   Google Scholar
• Sanofi-Pasteur MSD, data on file.
   Google Scholar
• Nordhein KV. Vaccine-agreement between KV Nordrhein and SHI. https://www.kvno.de/downloads/schutzimpfungen.pdf (accessed 06.05.2015).
   Google Scholar
• PSSRU, Personal Social Services Research Unit. http://www.pssru.ac.uk/pdf/uc/uc2010/uc2010_s10.pdf (accessed 21.04.2015).
   Google Scholar
• AMELI, Assurance Maladie en Ligne. http://www.ameli.fr/professionnels-de-sante/medecins/votre-convention/tarifs/tarifs-conventionnels-des-medecins-generalistes/tarifs-des-medecins-generalistes-en-metropole_rhone.php (accessed 10.06.2014).
   Google Scholar
• AIFA, Agenzia Italiana del Farmaco. http://www.agenziafarmaco.gov.it/en/content/pricing-and-reimbursement (accessed 28.08.2014).
   Google Scholar
• Diário da República, 1.ª série — N.º 20 — 29 de janeiro de 2014. Page 700, code 99070 and 99080
   Google Scholar
• Morano R, Pérez F, Brosa M, Pérez Escolano. Análisis de coste-efectividad de la vacunación antineumocócica en Espana. Gaz Sanit 2011; 25(4):267-273.
   Google Scholar